(Q30412771)

English

4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

1 reference

Europe PubMed Central

4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics (English)

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

0 references

Francesca Maria Trovato

object named as

Francesca Maria Trovato

1

0 references

Guglielmo M. Trovato

object named as

Guglielmo M Trovato

4

0 references

Giuseppe Musumeci

object named as

Giuseppe Musumeci

3

0 references

author name string

Daniela Catalano

2

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

publication date

7 December 2014

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

The EPMA journal

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

5

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

1

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

21

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

copyright license

Creative Commons Attribution 4.0 International

1 December 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Sedentary behavior: target for change, challenge to assess

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Clinical translation in the virtual liver network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Association of lifestyle factors and suboptimal health status: a cross-sectional study of Chinese students

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Towards personal health care with model-guided medicine: long-term PPPM-related strategies and realisation opportunities within 'Horizon 2020'.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Predictive, Preventive and Personalised Medicine as the hardcore of 'Horizon 2020': EPMA position paper

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

The genetics of NAFLD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Silymarin in non alcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Angiotensin-(1-7): beyond the cardio-renal actions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Insulin sparing action of adenovirus 36 and its E4orf1 protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Advantages of bariatric medicine for individualized prevention and treatments: multidisciplinary approach in body culture and prevention of obesity and diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Possible molecular mechanisms soy-mediated in preventing and treating nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Traditional, complementary and alternative medical systems and their contribution to personalisation, prediction and prevention in medicine-person-centred medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Misconduct accounts for the majority of retracted scientific publications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

The underlying interactome of childhood obesity: the potential role of sleep

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Behavior, nutrition and lifestyle in a comprehensive health and disease paradigm: skills and knowledge for a predictive, preventive and personalized medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Role of Body Mass Index, Waist-to-Height and Waist-to-Hip Ratio in Prediction of Nonalcoholic Fatty Liver Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Nutrition and nonalcoholic Fatty liver disease: the significance of cholesterol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Assessment of inflammation and fibrosis in non-alcoholic fatty liver disease by imaging-based techniques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

NAFLD in the absence of metabolic syndrome: different epidemiology, pathogenetic mechanisms, risk factors for disease progression?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

The role of metformin in the management of NAFLD

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Glitazones for human nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Probiotics in hepatology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Between brown and white: novel aspects of adipocyte differentiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Genetic determinants of hepatic steatosis in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Hepatocyte Death: A Clear and Present Danger

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Hepatitis C virus-induced steatosis: an overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Elevated endotoxin levels in non-alcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

The plasma lipidomic signature of nonalcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Development and evaluation of a questionnaire for measuring suboptimal health status in urban Chinese.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Olive oil consumption and non-alcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Mechanisms of disease progression in nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

The epidemiology of nonalcoholic fatty liver disease: a global perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Resveratrol inhibits nonalcoholic fatty liver disease in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Causes and metabolic consequences of Fatty liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Performance of transient elastography for the staging of liver fibrosis: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Role of radiologic modalities in the management of non-alcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Mechanisms and significance of liver steatosis in hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Lipid metabolism in hepatic steatosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Apoptosis: the nexus of liver injury and fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Adiponectin: a link between excess adiposity and associated comorbidities?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

20 June 2018

Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

A pathogenetic link between non-alcoholic fatty liver disease and celiac disease.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

[Hepatic stellate cells and oxidative stress]

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Regional anthropometric measures associated with the severity of liver injury in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Bright liver, body composition and insulin resistance changes with nutritional intervention: a follow-up study

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Accuracy and reliability of microbubble ultrasound measurements for the non-invasive assessment of hepatic fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

The utility of radiological imaging in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Serum markers detect the presence of liver fibrosis: a cohort study.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

A theoretical study of lipid accumulation in the liver-implications for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Dietary fat content modifies liver fat in overweight nondiabetic subjects.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Effects of dietary extra-virgin olive oil on oxidative stress resulting from exhaustive exercise in rat skeletal muscle: a morphological study

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Caffeine is protective in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Protective role of coffee in non-alcoholic fatty liver disease (NAFLD).

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Sleep-disordered breathing and insulin resistance in middle-aged and overweight men.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Continuous positive airway pressure improves sleep apnea associated fatty liver

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Western dietary pattern and sedentary life: independent effects of diet and physical exercise intensity on NAFLD.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Mediterranean diet and physical activity: an intervention study. Does olive oil exercise the body through the mind?

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Mediterranean diet: Relationship with anxiety and depression.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Re: "Relation of the traditional Mediterranean diet to cerebrovascular disease in a Mediterranean population".

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Renal function and severity of bright liver. Relationship with insulin resistance, intrarenal resistive index, and glomerular filtration rate.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Insulin resistance in postmenopausal women: concurrent effects of hormone replacement therapy and coffee

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Perceived body weight status of youngsters interferes with headache in obese and non-obese subjects

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Teens' obesity, noise and sleep deprivation: a perverse liaison. Let's move beyond "movida".

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Guidance on research integrity: no union in Europe.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Low levels of awareness of suboptimal health conditions in a high-risk working population: the "better health for better Hong Kong" health promotion campaign

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Health status, emotional/behavioral problems, health care use, and expenditures in overweight/obese US children/adolescents.

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Why do people with suboptimal health avoid health promotion at work?

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Mala-movida: late bed-timing and wake-up induce malnutrition and underweight in youngsters

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-5-21

21 January 2018

Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

26 November 2018

Stress, abdominal obesity and intrarenal resistive index in essential hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

26 November 2018

Gender, lifestyles, illness perception and stress in stable atrial fibrillation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

26 November 2018

Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

26 November 2018

Relationship between cardiac function and insulin resistance in obese patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4417534

26 November 2018

Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monounsaturated fat-rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoechoic lesions in the ‘bright liver': A reliable indicator of fatty change. A prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extra-virgin olive oil diet and mild physical activity prevent cartilage degeneration in an osteoarthritis model: an in vivo and in vitro study on lubricin expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human adenovirus-36 and non-alcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adipokines and cytokines in non-alcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast-like cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gut microbiota and nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-alcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Wine and good subjective health

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-alcoholic fatty liver disease in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/25937854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1878-5085-5-21

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30412771&oldid=2194831599"